Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
ATM Antibody (10H11.E12) - Azide and BSA Free, Novus Biologicals™

Mouse Monoclonal Antibody
Supplier: Novus Biologicals NBP280586
Description
ATM Monoclonal specifically detects ATM in Human, Mouse, Rat, Canine (Negative) samples. It is validated for Western Blot, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunoprecipitation, Immunohistochemistry-Paraffin.Specifications
ATM | |
Monoclonal | |
1 mg/mL | |
Western Blot : 1:1000, Immunohistochemistry 1:200, Immunocytochemistry/Immunofluorescence : 1:1000, Immunoprecipitation : 1:10-1:500, Immunohistochemistry-Paraffin : 1:200 | |
AT mutated, A-T mutated, AT1, ATA, ataxia telangiectasia mutated (includes complementation groups A, C and D), ataxia telangiectasia mutatedATD, ATC, ATDC, ATE, DKFZp781A0353, EC 2.7.11.1, MGC74674, serine-protein kinase ATM, TEL1, TEL1, telomere maintenance 1, homolog, TELO1 | |
Mouse | |
Protein G purified | |
RUO | |
Primary | |
Does not work in canine per customer review | |
Aliquot and store at -20°C or -80°C. Avoid freeze-thaw cycles. | |
IgG1 κ |
Western Blot, Immunohistochemistry, Immunofluorescence, Immunoprecipitation, Immunohistochemistry (Paraffin) | |
10H11.E12 | |
Unconjugated | |
Tris-Glycine, 0.15 M NaCl | |
ATM | |
Synthetic peptide made to a region surrounding the phosphorylated Serine 1981 of human ATM. [UniProt# Q13315] | |
0.1 mL | |
Apoptosis, Breast Cancer, Cancer, Cell Cycle and Replication, Checkpoint signaling, Chromatin Research, DNA Double Strand Break Repair, DNA Repair, Genes Sensitive to DNA Damaging Agents, Hypoxia, Modulation of DNA Pools, p53 Pathway, Phospho Specific, Tumor Suppressors | |
472 | |
Human, Mouse, Rat, Canine (Negative) | |
Purified |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction